Medical Care Technologies Inc Stock Price, News & Analysis

Medical Care Technologies (OTC Pink: MDCE) announced it has begun a new infrastructure and early system testing phase to scale its AI-driven health analytics platform on November 25, 2025. The company said work targets both a Clinical AI Division (clinical validation track) and a Consumer AI Division (preventive health, emotional wellness, dietary and lifestyle tools).

Preparatory activities listed include architecture optimization, module compatibility testing, data ingestion stress tests, early safety and compliance assessments, and predictive model tuning. Management framed these steps as groundwork for continued development and testing.

Medical Care Technologies (OTC Pink: MDCE) reported that its subsidiaries have generated $848,987 year-to-date, including $478,218 in Q3, while the company was ranked #2 on InvestorsHub's Breakout Board on November 21, 2025.

Infinite Auctions contributed six-figure revenue from a Fall Flash Auction and a consignment agreement with Fanatics Collect. Real Game Used, an AI-assisted authentication unit, maintains an order log of more than 50 high-end evaluations. The company says it is advancing testing, feature development, and infrastructure for upcoming AI-driven mobile health and nutrition products, with additional milestones to be announced in coming weeks.

Medical Care Technologies (OTC Pink: MDCE) subsidiary Infinite Auctions will conclude its Fall Flash Auction on Saturday, November 22, 2025 at 9:00 PM EST on www.infiniteauctions.com. The online event features a curated lineup of rare game-worn and autographed memorabilia from athletes including Michael Jordan, LeBron James, and Tiger Woods. Several highlight items were authenticated by Real Game Used (RGU), a company subsidiary using AI-driven photo-matching and artifact authentication. Collectors can view, register, and bid now on the auction site.

Medical Care Technologies (OTC PINK:MDCE) announced that CEO Marshall Perkins purchased 50,000,000 shares of MDCE common stock on the open market at an average price of $0.0003 per share on November 19, 2025.

The purchase was made with personal funds, did not involve issuance of new company shares, and therefore did not constitute a corporate action. The company reported an unchanged outstanding share count of 3,316,305,988 common shares as of the release date.

Management said the purchase reflects alignment with shareholders and ongoing focus on transparent communications while the company pursues activities in health technology and digital wellness.

Tom Brady collectible (NASDAQ:MDCE) — A 2009 Topps Unique Tom Brady 1-of-1 game-worn NFL Shield Patch Autograph card, graded PSA 6 (EX-MT), is live in Fanatics Collect Premier Auction with no reserve and the auction ends November 20, 2025. The unsigned 1-of-1 sold for $78,000 on September 25, 2025, and a comparable Brady 1/1 patch autograph sold for $485,000 at Sotheby’s in 2024, providing market context for expectations that this lot may breach six figures.

The card was consigned to Fanatics Collect via a consignment agreement with Infinite Auctions.

Medical Care Technologies (OTC PINK: MDCE) subsidiary Infinite Auctions consigned a one-of-one 2009 Topps Unique Tom Brady NFL Shield Patch Autograph card (serial 1/1) to Fanatics Collect's Premier Auction.

The card is graded PSA 6 EX-MT, features an authentic game-worn NFL Equipment patch and on-card Brady autograph, and is live for bidding now through Thursday, November 20, 2025 at 9:30 PM ET. Fanatics consignment staff indicated the card could achieve a six-figure sale. The release also notes a recent >$12 million one-of-one sale for a Michael Jordan/Kobe Bryant card and Tom Brady's 50% ownership stake in CardVault stores.

Medical Care Technologies (OTC PINK:MDCE) announced a patent-pending, multi-vertical AI health platform (U.S. Provisional Patent Application No. 63/854,935) that delivers real-time diagnostic screening via smartphones without specialized hardware.

The system targets four core verticals: mental health screening, wound monitoring, skin cancer detection, and a health risk estimator. MDCE cites target markets including a >$400B digital mental health market, $30B+ chronic wound care by 2030, $15B+ dermatology diagnostics, and a $4T preventative health sector. The company expects an integrated beta consumer app release in 2026, marking a move toward commercial deployment.

Medical Care Technologies (OTC Pink:MDCE) said it is entering the final phase of testing for its first consumer application and plans a beta launch in Q4 2025. The company indicated the beta could create immediate revenue potential upon launch and described this as part of a strategic expansion into consumer health and wellness tech using AI and digital health capabilities.

MDCE also said it is accelerating development of its coding and AI algorithms for its suite of medical applications to support future product releases and improved patient/user experience.

Medical Care Technologies (OTC PINK:MDCE) announced development of an AI-powered consumer wellness app suite on November 3, 2025. The suite targets 175 countries and 30 languages, focusing on non-clinical, accessible wellness insights across mental wellness, skin health, and diet and nutrition.

The company frames this as a wellness-first strategy to reach a global market valued at over $10 billion, aiming to avoid clinical approval timelines while expanding consumer reach and usability.